
Venom & antivenom research
We study the evolution, variation and biochemical activity of snake venom across species and settings. This evidence can inform the development of more effective, targeted therapeutics.
Research & innovation
Our cross-disciplinary approach links laboratory research, clinical investigation and public-health priorities to address the causes and consequences of snakebite envenoming.
Research pillars
We focus on complementary questions across venom science, clinical care and the wider systems that shape prevention and treatment.

We study the evolution, variation and biochemical activity of snake venom across species and settings. This evidence can inform the development of more effective, targeted therapeutics.

We investigate how snakebite affects patients across different health settings and regions, and assess the quality of current treatments and the impact of emerging therapeutics.

We address evidence gaps, engage stakeholders and work to raise the priority of snakebite on national health agendas.
Research priorities
Research is most useful when it responds to real needs and can be translated into better services and stronger public-health action.
Improve the evidence base on incidence, access to care and treatment outcomes.
Support attention to safe, effective, quality-assured and affordable antivenom.
Connect findings with clinical practice, public-health programmes and policy action.
Support research
Equitable research partnerships and responsible support can strengthen the evidence, capacity and collaboration needed to improve snakebite outcomes.